Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2026-06-10 19:00:39 ET · period of report 2026-06-09 · accession 0001563572-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 19:00 | 2026-06-09 | NTLA | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +9,200 | 143.9K | +7% | $0 |
| D | 2026-06-10 19:00 | 2026-06-09 | NTLA | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +13.3K | 13.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-09 | A | A | 9,200 | $0.00 | 143,893 | D | — | — | (F1) Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. |
| 2 | Derivative | Stock Option (right to buy) | 2026-06-09 | A | A | 13,300 | $0.00 | 13,300 | D | $12.89 · — to 2036-06-08 | 13,300 Common Stock | (F2) This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. |